ÐòºÅ | ҩƷͨÓÃÃû³Æ | Ó¢ÎÄÃû³Æ/ÉÌÆ·Ãû | ¹æ¸ñ | ³ÖÖ¤ÉÌ | ±¸×¢1 | ±¸×¢2 |
70-1 | »·¹èËáï¯ÄÆÉ¢ | Sodium Zirconium Cyclosilicate Powder/Àû±¶×¿? /LOKELMA ? | 5g | AstraZeneca AB | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔÑÐÈë¿Ú |
70-2 | »·¹èËáï¯ÄÆÉ¢ | Sodium Zirconium Cyclosilicate Powder/Àû±¶×¿? /LOKELMA ? | 10g | AstraZeneca AB | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔÑÐÈë¿Ú |
70-3 | ÁòËáÈðÃÀ¼ªãú¿Ú±ÀƬ | Rimegepant Sulfate/Nurtec Odt | 75mg | Biohaven Pharmaceutical Ireland Designated Activity Co/Pfizer Inc | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-4 | °±ÂȵØƽçÓɳ̹ÇâÂÈàçàºÆ¬ | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets/Exforge HCT | 5/160/12.5 mg | Novartis Pharmaceuticals Corporation | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-5 | °±ÂȵØƽçÓɳ̹ÇâÂÈàçàºÆ¬ | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets/Exforge HCT | 10/160/12.5 mg | Novartis Pharmaceuticals Corporation | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-6 | °±ÂȵØƽçÓɳ̹ÇâÂÈàçàºÆ¬ | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets/Exforge HCT | 5/160/25 mg | Novartis Pharmaceuticals Corporation | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-7 | °±ÂȵØƽçÓɳ̹ÇâÂÈàçàºÆ¬ | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets/Exforge HCT | 10/160/25 mg | Novartis Pharmaceuticals Corporation | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-8 | °±ÂȵØƽçÓɳ̹ÇâÂÈàçàºÆ¬ | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets/Exforge HCT | 10/320/25 mg | Novartis Pharmaceuticals Corporation | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-9 | °ÂµªÆ½ÈøÃ׶à·ÒƬ | Olanzapine and Samidorphan tablets / LYBALVI? | 5mg/10mg£¨°ÂµªÆ½/ÈøÃ׶à·Ò£© | Alkermes,Inc. | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-10 | °ÂµªÆ½ÈøÃ׶à·ÒƬ | Olanzapine and Samidorphan tablets / LYBALVI? | 10mg/10mg£¨°ÂµªÆ½/ÈøÃ׶à·Ò£© | Alkermes,Inc. | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-11 | °ÂµªÆ½ÈøÃ׶à·ÒƬ | Olanzapine and Samidorphan tablets / LYBALVI? | 15mg/10mg£¨°ÂµªÆ½/ÈøÃ׶à·Ò£© | Alkermes,Inc. | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-12 | °ÂµªÆ½ÈøÃ׶à·ÒƬ | Olanzapine and Samidorphan tablets / LYBALVI? | 20mg/10mg £¨°ÂµªÆ½/ÈøÃ׶à·Ò£© | Alkermes,Inc. | δÈë¿ÚÔÑÐÒ©Æ· | ÃÀ¹ú³ÈƤÊé |
70-13 | ×¢ÉäÓÃÌæÂíÎ÷ÆÕ | Lymphoseek 50 micrograms kit for radiopharmaceutical preparation tilmanocept/Lymphoseek | 50 ?g£¨ÒÔÌæÂíÎ÷Æռƣ© | Navidea Biopharmaceuticals Europe Ltd. | δÈë¿ÚÔÑÐÒ©Æ· | Å·ÃËÉÏÊÐ |
70-14 | ï½[99mTc]ÌæÂíÎ÷ÆÕ×¢ÉäÒº | technetium Tc 99m tilmanocept injection/Lymphoseek | N/A | Navidea Biopharmaceuticals Europe Ltd. | δÈë¿ÚÔÑÐÒ©Æ· | Å·ÃËÉÏÊÐ |
70-15 | ¶þ¶¡õ£»·Á×ÏÙÜÕÄÆÈí¸à | Bucladesine Sodium ointment/ Actosin ointment | 3%£¨Ã¿¿Ëº¬¶þ¶¡õ£»·Á×ÏÙÜÕÄÆ30mg£© | ¥Ë¥×¥í¥Õ¥¡©`¥ÞÖêʽ»áÉç | δÈë¿ÚÔÑÐÒ©Æ· | ÈÕ±¾ÉÏÊÐ |
70-16 | °¢·¥ÌæÄáƬ | Avapritinib Tablets/Ì©¼ª»ª?Ayvakit? | 100mg | Blueprint Medicines Corporation | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔÑÐÈë¿Ú |
70-17 | °¢·¥ÌæÄáƬ | Avapritinib Tablets/Ì©¼ª»ª? Ayvakit? | 200mg | Blueprint Medicines Corporation | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔÑÐÈë¿Ú |
70-18 | °¢·¥ÌæÄáƬ | Avapritinib Tablets/Ì©¼ª»ª? Ayvakit? | 300mg | Blueprint Medicines Corporation | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔÑÐÈë¿Ú |
70-19 | ±ûÁòÑõà×à¤Æ¬ | Propylthiouracil Tablets | 50mg | Hemony Pharmaceutical Germany GmbH | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔÑÐÈë¿Ú |
70-20 | ¸£ÐÁÆÕÀûÄÆƬ | Fosinopril sodium/ÃÉŵ | 10mg | ÖÐÃÀÉϺ£Ê©¹ó±¦ÖÆÒ©ÓÐÏÞ¹«Ë¾ | ¾ÉóºËÈ·¶¨µÄÍâÑóÔÑÐÆóÒµÔÚÖйú¾³ÄÚÉú²úµÄÒ©Æ· | ÔÑеزú»¯ |
70-21 | Á×ËáÎ÷¸ñÁÐ͡Ƭ | Sitagliptin Phosphate Tablets/½Ýŵά | 100 mg | º¼ÖÝĬɳ¶«ÖÆÒ©ÓÐÏÞ¹«Ë¾ | ¾ÉóºËÈ·¶¨µÄÍâÑóÔÑÐÆóÒµÔÚÖйú¾³ÄÚÉú²úµÄÒ©Æ· | ÔÑеزú»¯ |
8-44 | ¶ÔÒÒõ£°±»ù·ÓÅÝÌÚƬ | Paracetamol Effervescent Tablets/Panadol ActiFast Soluble Tablets | 0.5g | GlaxoSmithKline Consumer Healthcare | δÈë¿ÚÔÑÐÒ©Æ· | Å·ÃËÉÏÊÐ |
22-443 | ÑÎËá×óɳ¶¡°·´¼Îí»¯ÎüÈëÈÜÒº | Levalbuterol hydrochloride Inhalation Solution / XOPENEX | 0.63mg/3ml | OAK PHARMACEUTICALS INC SUBSIDIARY OF AKORN INC/Akorn | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌAkorn |
22-444 | ÑÎËá×óɳ¶¡°·´¼Îí»¯ÎüÈëÈÜÒº | Levalbuterol hydrochloride Inhalation Solution / XOPENEX | 0.31mg/3ml | OAK PHARMACEUTICALS INC SUBSIDIARY OF AKORN INC/Akorn | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌAkorn |
23-179 | ÑÎËáËûÅçËû¶à»ºÊÍƬ | Tapentadol Hydrochloride Extended Release Tablets/Nucynta Er | Eq 50mg Base | Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌCollegium Pharmaceutical Inc |
23-180 | ÑÎËáËûÅçËû¶à»ºÊÍƬ | Tapentadol Hydrochloride Extended Release Tablets/Nucynta Er | Eq100mg Base | Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌCollegium Pharmaceutical Inc |
23-181 | ÑÎËáËûÅçËû¶à»ºÊÍƬ | Tapentadol Hydrochloride Extended Release Tablets/Nucynta Er | Eq150mg Base | Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌCollegium Pharmaceutical Inc |
23-182 | ÑÎËáËûÅçËû¶à»ºÊÍƬ | Tapentadol Hydrochloride Extended Release Tablets/Nucynta Er | Eq200mg Base | Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌCollegium Pharmaceutical Inc |
23-183 | ÑÎËáËûÅçËû¶à»ºÊÍƬ | Tapentadol Hydrochloride Extended Release Tablets/Nucynta Er | Eq250mg Base | Depo Nf Sub LLC A Sub Of Assertio Therapeutics Inc/Collegium Pharmaceutical Inc | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌCollegium Pharmaceutical Inc |
23-197 | ÒÀÕÛÂó²¼ÈðÊæ·¥ËûÍ¡¸ÆƬ | Ezetimibe rosuvastatin calcium film-coated tablet | ÒÀÕÛÂó²¼10mg/ÈðÊæ·¥ËûÍ¡10mg | Sanofi-Aventis, S.R.O./Sanofi-Aventis Ireland Limited T/A SANOFI | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌSanofi-Aventis Ireland Limited T/A SANOFI |
26-36 | °¢ÆæùËصÎÑÛÒº | Azithromycin Ophthalmic Solution/ Azasite | 1% | Oka Pharmaceuticals Inc Subsidary Of Akorn Inc/Thea pharma inc | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌThea pharma inc |
26-87 | ÑÎËá·ÇË÷·ÇÄǶ¨¿Ú·þ»ìÐüÒº | Fexofenadine Hydrochloride Oral Suspension / Children¡¯s Allegra Allergy | 30mg/5ml | Sanofi Aventis US LLC/Chattem Inc Dba Sanofi Consumer Healthcare | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌChattem Inc Dba Sanofi Consumer Healthcare |
27-421 | ×ó¼××´ÏÙËØÄÆƬ | Levothyroxine Sodium Tablets/Euthyrox;Levothyrox | 25¦Ìg£¨ÒÔ×ó¼××´ÏÙËØÄƼƣ© | Merck Serono GmbH/Merck Sante/Merck Gesellschaft mbH/Merck BV | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌMerck BV |
27-423 | ×ó¼××´ÏÙËØÄÆƬ | Levothyroxine Sodium Tablets/Euthyrox;Levothyrox | 100¦Ìg£¨ÒÔ×ó¼××´ÏÙËØÄƼƣ© | Merck Serono GmbH/Merck Sante/Merck Gesellschaft mbH/Merck BV | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌMerck BV |
30-116 | ¶¡ä嶫ݹÝмî×¢ÉäÒº | Scopolamine Butylbromide Injection/ Buscapina/Buscopan | 1ml:20mg | Sanofi-aventis/Sanofi/Aventis/Sanofi S.p.A./Sanofi-Aventis Deutschland GmbH | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌSanofi-Aventis Deutschland GmbH |
39-39 | ×ó¼××´ÏÙËØÄÆƬ | Levothyroxine Sodium Tablets | 200¦Ìg£¨ÒÔ×ó¼××´ÏÙËØÄƼƣ© | Merck Serono GmbH/Merck Sante/Merck Gesellschaft mbH/Merck BV | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌMerck BV |
42-25 | ÑÎËá·úÎ÷Í¡¿Ú·þÈÜÒº | Fluoxetine Hydrochloride Oral Solution/PROZAC | 20mg/5ml | Lilly France/Eli Lilly Italia S.p.A./Eli Lilly Nederland B.V. | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌEli Lilly Nederland B.V. |
63-3 | ÎÞË®ÒÒ´¼×¢ÉäÒº | Anhydrous Ethanol Injection/ABLYSINOL | 99%£¨5ml£© | BELCHER PHARMACEUTICALS LLC / BPI Labs, LLC | δÈë¿ÚÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌBPI Labs, LLC |
8-7 | °¢ÂØì¢ËáÄÆάD3Ƭ | Alendronate Sodium and Vitamin D3 Tablets/-- | °¢ÂØì¢ËáÄÆ£¨ÒÔC4H13NO7P2¼Æ£©70mgºÍάÉúËØD3 2800IU | Merck Sharp & Dohme Ltd./N.V. Organon | ÔÑÐÈë¿Ú | ÔöÌí³ÖÖ¤ÉÌN.V. Organon |
8-220 | °¢ÂØì¢ËáÄÆάD3Ƭ | Alendronate Sodium and Vitamin D3 Tablets/-- | °¢ÂØì¢ËáÄÆ£¨ÒÔC4H13NO7P2¼Æ£©70mgºÍάÉúËØD3 5600IU | Merck Sharp & Dohme Ltd./N.V. Organon | ÔÑÐÈë¿Ú | ÔöÌí³ÖÖ¤ÉÌN.V. Organon |
10-58 | ¹Ç»¯Èý´¼Èí½ºÄÒ/¹Ç»¯Èý´¼½ºÍè | Calcitriol Soft Capsules/Rocaltrol | 0.25¦Ìg | Roche Pharma£¨Schweiz£© Ltd./Atnahs Pharma UK Limited/Roche Pharma£¨Schweiz£©AG | ÔÑÐÈë¿Ú | ÔöÌí³ÖÖ¤ÉÌRoche Pharma£¨Schweiz£© AG |
10-219 | ·üÁ¢¿µßò¸É»ìÐü¼Á | Voriconazole for Oral Suspension/Vfend | 45g£º3g | Pfizer Limited/Pfizer Europe MA EEIG | ÔÑÐÈë¿Ú | ÔöÌí³ÖÖ¤ÉÌPfizer Europe MA EEIG |
21-151 | ¿·ËáĪÃ×ËɱÇÅçÎí¼Á | Mometasone Furoate Aqueous Nasal Spray/ Nasonex£¨ÄÚÊæÄã© | 50¦Ìg/Þ죨0.05%£© | MSD Belgium BVBA/SPRL | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌOrganon Belgium |
38-8 | ¸´·½±¶ËûÃ×ËÉ×¢ÉäÒº | Compound Betamethasone Injection/µÃ±¦ËÉ | 1ml£º¶þ±ûËᱶËûÃ×ËÉ£¨ÒÔ±¶ËûÃ×Ëɼƣ©5mgÓ뱶ËûÃ×ËÉÁ×ËáÄÆ£¨ÒÔ±¶ËûÃ×Ëɼƣ©2mg | MSD Merck Sharp & Dohme AG/Organon GmbH | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌOrganon GmbH |
69-8 | ̼ËáÇâÄÆѪÂËÖû»Òº | Hemofiltration Replacement Fluid of Sodium Bicarbonate | 5000ml | Gambro Lundia AB / Baxter Holding B.V. | º£ÄÚÉÏÊеÄÔÑÐÒ©Æ· | ÔöÌí³ÖÖ¤ÉÌBaxter Holding B.V. |
24-57 | °±¼ºÏ©Ëá¿Ú·þÈÜÒºÓÃÉ¢ | Vigabatrin For Oral Solution/Vigabatrin Powder for Oral Solution/Sabril | 500mg/packet | Lundbeck Pharmaceuticals LLC | δÈë¿ÚÔÑÐÒ©Æ· | ҩƷͨÓÃÃû³ÆÐÞ¶©Îª°±¼ºÏ©Ëá¿Ú·þÈÜÒºÓÃÉ¢£¬Ó¢ÎÄÃû³ÆÔöÌíVigabatrin Powder for Oral Soluti¸üÕýon¡£ |
56-29 | ×¢ÉäÓÃÅàÃŶ¬Ã¸ | Pegaspargase For Injection / Oncaspar | 3750U£¨750U/Ml£© | Les Laboratoires Servier | δÈë¿ÚÔÑÐÒ©Æ· | ³ÖÖ¤ÉÌÐÞ¶©Îª£ºLes Laboratoires Servier |
56-31 | Î÷ÂÞĪ˾Äý½º | Sirolimus Topical Gel /Sirolimus Gel/Rapalimus | 0.2% | ¥Î©`¥Ù¥ë¥Õ¥¡©`¥ÞÖêʽ»áÉç | δÈë¿ÚÔÑÐÒ©Æ· | ҩƷͨÓÃÃû³ÆÐÞ¶©ÎªÎ÷ÂÞĪ˾Äý½º£¬Ó¢ÎÄÃû³ÆÔöÌíSirolimus Gel |
±¸×¢ | 1.Ŀ¼ÖÐËùÁÐÉÐδÔÚº£ÄÚÉÏÊÐÆ·ÖÖµÄͨÓÃÃû¡¢¼ÁÐ͵ȣ¬ÒÔÒ©µäίÅú×¼µÄΪ׼¡£ 2.²Î±ÈÖƼÁĿ¼¹«Ê¾ºó£¬Î´ÕýʽÐû²¼µÄÆ·ÖÖ½«¾ÙÐÐרÌâÑо¿£¬Æ¾Ö¤Ñо¿Ð§¹ûÁíÐÐÐû²¼¡£ 3.Å·ÃËÉÏÊеIJαÈÖƼÁ°üÀ¨ÆäÔÚÓ¢¹úÉÏÊеÄͳһҩƷ¡£ 4.Ñ¡ÔñδÈë¿Ú²Î±ÈÖƼÁ¿ªÕ¹·ÂÖÆÒ©Ñо¿³ýÖª×ãÆäÖÊÁ¿ÒªÇóÍ⣬»¹ÐèÖª×ãÏÖÐа桶ÖйúÒ©µä¡·ºÍÏà¹ØÖ¸µ¼ÔÔòÒªÇó¡£ 5.·ÅÉäÐÔÒ©Îï²î±ðÓÚͨË×»¯Ñ§Ò©Î¾ßÓÐÒ»¶¨µÄÌØÊâÐÔÈç·ÅÉäÐÔ¡¢Ê±Ð§ÐÔ¡¢°´·ÅÉäÐÔ»î¶È¸øÒ©µÈÌص㣬²Î±ÈÖƼÁÖ÷ÒªÓÃÓÚÃ÷È·ÆäÑз¢Ä¿µÄºÍ»ù±¾ÒªÇ󣬿Éƾ֤ÆäÒ©ÎïÌØÕ÷ͬʱÍŽá²Î±ÈÖƼÁµÄ¿É»ñµÃÐÔ¾ÙÐÐÑо¿¡£ |